Lexaria Bioscience Corp. (LEXX)

0.9802 -0.01 (-1.38%) USD  |  NASDAQ  |  Apr 21, 09:54
More

Lexaria Bioscience Cash and Short Term Investments (Quarterly) : 5.269M for Feb. 28, 2026

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for LEXX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Short Term Investments Definition

View Cash and Short Term Investments Definition
Start Trial

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Oncolytics Biotech, Inc. 5.202M
Aurinia Pharmaceuticals, Inc. 398.00M
Edesa Biotech, Inc. 12.05M
Xenon Pharmaceuticals, Inc. 548.89M
ProMIS Neurosciences, Inc. 6.150M